Potential therapeutic role of peroxisome proliferator activated receptor-γ agonists in psoriasis

By Malhotra Samir   Bansal Dipika   Shafiq Nusrat   Pandhi Promila   Kumar Bhushan  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1455-1461

Informa Healthcare

Access to resources Recommend Favorite

Neuropeptide Y1 and Y5 Receptor Antagonists as Potential Anti-Obesity Drugs: Current Status

By  

Mini Reviews in Medicinal Chemistry, Vol. 14, Iss. 11, 2014-10 ,pp. : 896-919

Bentham Science Publishers

Access to resources Recommend Favorite

Peroxisome Proliferator-Activated Receptor-γ and its Agonists in Hypertension and Atherosclerosis: Mechanisms and Clinical Implications

By Halabi Carmen M.   Sigmund Curt D.  

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 6, 2005-01 ,pp. : 389-398

Adis International

Access to resources Recommend Favorite

Melanin-concentrating hormone receptor antagonists as potential antiobesity agents

By Carpenter Andrew J   Hertzog Donald L  

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 11, 2002-11 ,pp. : 1639-1646

Informa Healthcare

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor-γ ligands as investigational modulators of angiogenesis

By Giaginis Costas   Margeli Alexandra   Theocharis Stamatios  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1561-1572

Informa Healthcare

Access to resources Recommend Favorite